Merit Medical Systems, Inc.

Equities

MMSI

US5898891040

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
73.78 ^USD	+0.55%		+2.43%	-2.87%

Mar. 19	Merit Medical Launches Micro ACE Micro-Access System in US	MT
Mar. 19	Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System	CI

Merit Medical Systems, Inc. Provides Revenue Guidance for the Year 2023

January 08, 2024 at 09:05 am EST

Merit Medical Systems, Inc. provided revenue guidance for the year 2023. For the year 2023 reported preliminary unaudited revenue in the range of approximately $1.255 billion - $1.259 billion, up approximately 9.0% - 9.4% year-over-year.

Latest news about Merit Medical Systems, Inc.

Merit Medical Launches Micro ACE Micro-Access System in US	Mar. 19	MT
Merit Medical Systems, Inc. Launches the Micro Ace Advanced Micro-Access System	Mar. 19	CI
Merit Medical Systems Insider Sold Shares Worth $479,182, According to a Recent SEC Filing	Mar. 14	MT
Merit Medical Systems Insider Sold Shares Worth $1,891,925, According to a Recent SEC Filing	Mar. 08	MT
Merit Medical Systems Insider Sold Shares Worth $1,380,513, According to a Recent SEC Filing	Mar. 05	MT
Needham Ups Price Target on Merit Medical Systems to $88 From $81, Maintains Buy Rating	Feb. 29	MT
Barrington Ups Price Target on Merit Medical Systems to $98 From $96, Maintains Outperform Rating	Feb. 29	MT
Oppenheimer Raises Merit Medical Systems Price Target to $87 From $82, Maintains Outperform Rating	Feb. 29	MT
Merit Medical Systems Q4 Non-GAAP Earnings, Revenue Advance	Feb. 29	MT
Transcript : Merit Medical Systems, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
(MMSI) MERIT MEDICAL SYSTEMS Expects Fiscal Year 2024 EPS Range $3.28 - $3.35	Feb. 28	MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q4 Revenue $324.5M, vs. Street Est of $320.6M	Feb. 28	MT
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Posts Q4 EPS $0.81, vs. Street Est of $0.77	Feb. 28	MT
Merit Medical Systems, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024	Feb. 28	CI
Merit Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Merit Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Merit Medical Systems Gets FDA Clearance For New Surgical Guidance System	Feb. 15	MT
Merit Medical Systems, Inc. Receives FDA 510(K) Clearance for Scout MD Surgical Guidance System	Feb. 15	CI
Raymond James Adjusts Price Target on Merit Medical Systems to $89 From $84, Keeps Outperform Rating	Jan. 30	MT
Merit Medical Systems Insider Sold Shares Worth $1,600,000, According to a Recent SEC Filing	Jan. 24	MT
Merit Medical Systems Enrolls First Patient in Knee Osteoarthritis Trial with Embosphere Microspheres	Jan. 16	MT
Merit Medical Systems, Inc. Enrolls First Patient in Merit Medical?s MOTION Study	Jan. 16	CI
Piper Sandler Raises Price Target on Merit Medical Systems to $95 From $88, Keeps Overweight Rating	Jan. 12	MT
Transcript : Merit Medical Systems, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 04:30 PM	Jan. 08
Merit Medical Systems, Inc. Provides Revenue Guidance for the Year 2023	Jan. 08	CI

Chart Merit Medical Systems, Inc.

Duration

Period

More charts

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-30 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Merit Medical Systems, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

73.78 USD

Average target price

93.05 USD

Spread / Average Target

+26.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MERIT MEDICAL SYSTEMS, INC.	-2.87%	4.27B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution